Manufacturer copay assistance · Vabysmo (J2777) · Genentech
$0 · Maximum benefit $15,000/year · Covers drug and administration costs
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Vabysmo — check the full fund board.
Run a benefits estimate for Vabysmo — the program's cap applies against the patient share CareCost calculates.
Yes — Genentech Ophthalmology Co-pay Program from Genentech. $0. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
$0 Maximum benefit: $15,000/year. Covers drug and administration costs
Accepted insurance: commercial. Not eligible: medicare, medicaid, government. Income limit: No income requirement.